Paratek Pharmaceuticals (PRTK) PT Maintained at $50 at Cantor Fitzgerald on Omadacycline NDA Acceptance; 'Time to Make PRTK a Priority' Apr 5, 2018 01:50PM
Paratek Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences Aug 22, 2017 08:00AM
Paratek Pharmaceuticals (PRTK): Sell-off After Positive Data Is Overdone - Cantor Jul 20, 2017 07:48AM
Pre-Open Movers 06/22: (ORCL) (HAIN) (SPLS) (AA) Higher; (ENSC) (KMDA) (SCS) Lower (more...) Jun 22, 2017 09:31AM
After-Hours Stock Movers 06/21: (ORCL) (PRTK) (NRZ) Higher; (SCS) (JCAP) (THMC) Lower (more...) Jun 21, 2017 05:52PM


Jun 21, 2017 04:34PM Cantor Fitzgerald Assumes Paratek Pharmaceuticals (PRTK) at Overweight
Apr 4, 2017 07:42AM Paratek Pharmaceuticals (PRTK): Omadacycline Hits Primary Endpoints - Cantor
Mar 30, 2017 07:32AM Paratek Pharmaceuticals (PRTK): Raising PT After Non Deal Roadshow - Cantor
Mar 6, 2017 07:14AM Paratek Pharmaceuticals (PRTK): Earnings Behind Us, Look To Upcoming Readouts - Cantor
Mar 2, 2017 07:30AM Paratek Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter 2016 Financial Results and Provides Clinical Update
Mar 30, 2016 09:20AM Cantor Fitzgerald Assumes Paratek Pharmaceuticals (PRTK) at Buy
Oct 15, 2015 05:27PM Profile Technologies (PRTK) Enters $50M Controlled Equity Offering Agreement
Aug 5, 2015 11:33AM Paratek Pharmaceuticals (PRTK) Bullish Stance Reiterated at Cantor Fitzgerald as Pivotal Trials Brings NDA One Step Closer
Jun 17, 2015 04:01PM Paratek Pharmaceuticals to Present at Upcoming Banking Conferences
May 11, 2015 04:13PM Cantor Fitzgerald Starts Paratek Pharmaceuticals (PRTK) at Buy
May 5, 2015 04:01PM Paratek Announces Closing of Common Stock Offering
Apr 29, 2015 11:30PM Paratek Announces Pricing of Public Offering of 2,860,000 Shares of Common Stock
Apr 27, 2015 05:00PM Profile Technologies (PRTK) Commences $60M Common Stock Offering
Apr 27, 2015 04:01PM Paratek Announces Proposed Public Offering of Common Stock